Blood group antigen studies using CdTe quantum dots and flow cytometry

Autor: Cabral Filho PE, Pereira MIA, Fernandes HP, de Thomaz AA, Cesar CL, Santos BS, Barjas-Castro ML, Fontes A

Publikováno v: International Journal of Nanomedicine, Vol 2015, Iss default, Pp 4393-4404 (2015)

Paulo E Cabral Filho,1 Maria IA Pereira,1 Heloise P Fernandes,2 Andre A de Thomaz,3 Carlos L Cesar,3 Beate S Santos,4 Maria L Barjas-Castro,2 Adriana Fontes1 1Departamento de Biofísica e Radiobiologia, Universidade Federal de Pernambuco, Recife, Per

Externí odkaz: https://doaj.org/article/707a8b5b6b79455385eb304d89a283b2

APLICAÇÃO DO ALGORITMO REVERSO ASSOCIADO A UM TERCEIRO TESTE TREPONÊMICO PARA TRIAGEM DE SÍFILIS NOS DOADORES DE SANGUE DO HEMOCENTRO UNICAMP

Autor: Macedo, MD, Rocha, GQ, Kurihara, GF, Ormenese, A, Barjas-Castro, ML, Addas-Carvalho, M, Furlanetto, ACMA

Publikováno v: In Hematology, Transfusion and Cell Therapy October 2024 46 Supplement 4:S892-S893

DOENÇA DA AGLUTININA FRIA (CAD) E SÍNDROME DA AGLUTINA FRIA (CAS): INVESTIGAÇÃO LABORATORIAL SEGUNDO CONSENSO INTERNACIONAL 2020

Autor: Moretto, FA, Sousa, ACT, Fernandes, HP, Barjas-Castro, ML

Publikováno v: In Hematology, Transfusion and Cell Therapy October 2024 46 Supplement 4:S801-S802

Real-world use of mycophenolate mofetil in inflammatory bowel disease: Results from the ENEIDA registry

Autor: Hernández-Camba A, Arranz L, Vera I, Carpio D, Calafat M, Lucendo AJ, Taxonera C, Marín S, Garcia MJ, Marín GS, Rodríguez ES, Carbajo AY, De Castro ML, Iborra M, Martin-Cardona A, Rodríguez-Lago I, Busquets D, Bertoletti F, Ausín MS, Tardillo C, Malaves JH, Bujanda L, Castaño A, Domènech E, Ramos L

Publikováno v: Digestive and Liver Disease
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname

BACKGROUND: Studies to evaluate the use of mycophenolate mofetil (MMF) in inflammatory bowel disease (IBD) are limited after the appearance of biological treatments. AIMS: Our primary objective was to evaluate the effectiveness and safety of MMF in I

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::3eb9c616e5941b971d98ff7451b48b8a
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=5270

Effectiveness and Safety of the Switch from Remicade (R) to CT-P13 in Patients with Inflammatory Bowel Disease

Autor: Chaparro, M, Garre, A, Veloz, MFG, Moron, JMV, De Castro, ML, Leo, E, Rodriguez, E, Carbajo, AY, Riestra, S, Jimenez, I, Calvet, X, Bujanda, L, Rivero, M, Gomollon, F, Benitez, JM, Bermejo, F, Alcaide, N, Gutierrez, A, Manosa, M, Iborra, M, Lorente, R, Rojas-Feria, M, Barreiro-de Acosta, M, Kolle, L, Van Domselaar, M, Amo, V, Arguelles, F, Ramirez, E, Morell, A, Bernardo, D, Gisbert, JP

Publikováno v: JOURNAL OF CROHNS & COLITIS
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
r-FISABIO. Repositorio Institucional de Producción Científica
instname
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Journal of Crohn's & colitis
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe

Background and Aims: To evaluate the clinical outcomes in patients with IBD after switching from Remicade (R) to CT-P13 in comparison with patients who maintain Remicade (R). Methods: Patients under Remicade (R) who were in clinical remission with st

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::159f19d6eb870ebf2c08867b5dd6c22b
https://fundanet.fisabio.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=5447